Fingerprint
Dive into the research topics of 'Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia
P. Charbel Issa, R. P. Finger, F. G. Holz, H. P.N. Scholl
Research output: Contribution to journal › Article › peer-review
67
Scopus
citations